MicroRNA and Oxidative Stress Interplay in the Context of Breast Cancer Pathogenesis

被引:29
作者
Cosentino, Giulia [1 ]
Plantamura, Ilaria [1 ]
Cataldo, Alessandra [1 ,2 ]
Iorio, Marilena V. [1 ,2 ]
机构
[1] Fdn IRCCS Ist Nazl Tumori, Res Dept, Mol Targeting Unit, I-20133 Milan, Italy
[2] IFOM Ist FIRC Oncol Mol, I-20139 Milan, Italy
关键词
oxidative stress; miRNAs; breast cancer; ROS; NF-KAPPA-B; REGULATES NRF2 EXPRESSION; OXYGEN SPECIES ROS; MOLECULAR SUBTYPES; DRUG-RESISTANCE; TUMOR-GROWTH; CELLS; PATHWAY; SURVIVAL; CONTRIBUTES;
D O I
10.3390/ijms20205143
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress is a pathological condition determined by a disturbance in reactive oxygen species (ROS) homeostasis. Depending on the entity of the perturbation, normal cells can either restore equilibrium or activate pathways of cell death. On the contrary, cancer cells exploit this phenomenon to sustain a proliferative and aggressive phenotype. In fact, ROS overproduction or their reduced disposal influence all hallmarks of cancer, from genome instability to cell metabolism, angiogenesis, invasion and metastasis. A persistent state of oxidative stress can even initiate tumorigenesis. MicroRNAs (miRNAs) are small non coding RNAs with regulatory functions, which expression has been extensively proven to be dysregulated in cancer. Intuitively, miRNA transcription and biogenesis are affected by the oxidative status of the cell and, in some instances, they participate in defining it. Indeed, it is widely reported the role of miRNAs in regulating numerous factors involved in the ROS signaling pathways. Given that miRNA function and modulation relies on cell type or tumor, in order to delineate a clearer and more exhaustive picture, in this review we present a comprehensive overview of the literature concerning how miRNAs and ROS signaling interplay affects breast cancer progression.
引用
收藏
页数:13
相关论文
共 96 条
[1]   miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP1 [J].
Akdemir, Burak ;
Nakajima, Yasuaki ;
Inazawa, Johji ;
Inoue, Jun .
MOLECULAR CANCER RESEARCH, 2017, 15 (11) :1570-1578
[2]  
[Anonymous], BREAST CANC RES
[3]   Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents [J].
Bajor, Malgorzata ;
Zych, Agata O. ;
Graczyk-Jarzynka, Agnieszka ;
Muchowicz, Angelika ;
Firczuk, Malgorzata ;
Trzeciak, Lech ;
Gaj, Pawel ;
Domagala, Antoni ;
Siernicka, Marta ;
Zagozdzon, Agnieszka ;
Siedlecki, Pawel ;
Kniotek, Monika ;
O'Leary, Patrick C. ;
Golab, Jakub ;
Zagozdzon, Radoslaw .
BRITISH JOURNAL OF CANCER, 2018, 119 (07) :873-884
[4]   Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity [J].
Bao, Bin ;
Mitrea, Cristina ;
Wijesinghe, Priyanga ;
Marchetti, Luca ;
Girsch, Emily ;
Farr, Rebecca L. ;
Boerner, Julie L. ;
Mohammad, Ramzi ;
Dyson, Greg ;
Terlecky, Stanley R. ;
Bollig-Fischer, Aliccia .
SCIENTIFIC REPORTS, 2017, 7
[5]   Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential [J].
Batinic-Haberle, Ines ;
Reboucas, Julio S. ;
Spasojevic, Ivan .
ANTIOXIDANTS & REDOX SIGNALING, 2010, 13 (06) :877-918
[6]   Manganese superoxide dismutase in breast cancer: From molecular mechanisms of gene regulation to biological and clinical significance [J].
Becuwe, Philippe ;
Ennen, Marie ;
Klotz, Remi ;
Barbieux, Claire ;
Grandemange, Stephanie .
FREE RADICAL BIOLOGY AND MEDICINE, 2014, 77 :139-151
[7]   Aquaporin-facilitated transmembrane diffusion of hydrogen peroxide [J].
Bienert, Gerd P. ;
Chaumont, Francois .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2014, 1840 (05) :1596-1604
[8]   miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A [J].
Bott, Alexander ;
Erdem, Nese ;
Lerrer, Shalom ;
Hotz-Wagenblatt, Agnes ;
Breunig, Christian ;
Abnaof, Khalid ;
Woerner, Angelika ;
Wilhelm, Heike ;
Muenstermann, Ewald ;
Ben-Baruch, Adit ;
Wiemann, Stefan .
ONCOTARGET, 2017, 8 (27) :43897-43914
[9]   hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer [J].
Camps, Carme ;
Buffa, Francesca M. ;
Colella, Stefano ;
Moore, John ;
Sotiriou, Christos ;
Sheldon, Helen ;
Harris, Adrian L. ;
Gleadle, Jonathan M. ;
Ragoussis, Jiannis .
CLINICAL CANCER RESEARCH, 2008, 14 (05) :1340-1348
[10]   The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes [J].
Carey, Lisa A. ;
Dees, E. Claire ;
Sawyer, Lynda ;
Gatti, Lisa ;
Moore, Dominic T. ;
Collichio, Frances ;
Ollila, David W. ;
Sartor, Carolyn I. ;
Graham, Mark L. ;
Perou, Charles M. .
CLINICAL CANCER RESEARCH, 2007, 13 (08) :2329-2334